Physician profile
Michael E Clifford
NPI 1366584013
$4,383.98
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $1,265 · 2021: $1,530 · 2022: $516.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,049.22 | 2019-2022 | |
| Amgen INC. | $831.32 | 2019-2022 | |
| Ucb, INC. | $737.59 | 2019-2022 | |
| Janssen Biotech, INC. | $623.65 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $300.82 | 2019-2022 | |
| Lilly USA, LLC | $197.74 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $172.66 | 2019-2021 | |
| Genentech USA, INC. | $166.93 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.27 | 2020-2021 | |
| Sobi, INC | $53.50 | 2019-2020 | |
| Organon LLC | $45.38 | 2022 | |
| Glaxosmithkline, LLC. | $41.41 | 2019-2021 | |
| Vyaire Medical, INC. | $36.41 | 2021 | |
| Merck Sharp & Dohme LLC | $21.98 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.68 | 2019 | |
| Kci USA, INC. | $15.69 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clifford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.